Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 1/20 | 0.61 |
| ▸ | TYR | P14679 | 1/20 | 0.61 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | ERN1 | O75460 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.54 |
| ▸ | POLB | P06746 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | AKR1C3 | P42330 | 4/20 | 0.48 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29955976 | 1.00 | TRIM24 (0.61) | TRIM24TYRTRIM33ALDH1A1ERN1 | |
| SCHEMBL13329535 | 0.86 | TRIM24 (0.61) | TRIM24TYRTRIM33ALDH1A1ERN1 | |
| SCHEMBL4733806 | 0.86 | ERN1 (0.61) | TRIM24TYRTRIM33ALDH1A1ERN1 | |
| SCHEMBL4476198 | 0.84 | TRIM24 (0.59) | TRIM24TYRTRIM33ALDH1A1ERN1 | |
| SCHEMBL12837795 | 0.84 | SMN1; SMN2 (0.54) | TRIM24TYRTRIM33ALDH1A1SMN1; SMN2 | |
| SCHEMBL7302719 | 0.84 | TRIM24 (0.59) | TRIM24TYRTRIM33ALDH1A1ERN1 | |
| SCHEMBL10457145 | 0.83 | KDM4E (0.58) | ALDH1A1SMN1; SMN2KDM4ELMNAHPGD | |
| SCHEMBL7235657 | 0.82 | ALDH1A1 (0.61) | TRIM24TYRTRIM33ALDH1A1ERN1 | |
| SCHEMBL29956204 | 0.81 | TRIM24 (0.56) | TRIM24TYRTRIM33ALDH1A1ERN1 | |
| SCHEMBL11530087 | 0.81 | TRIM24 (0.56) | TRIM24TYRTRIM33ALDH1A1ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118580016-A | Nicotinamide ribochlorate-based salicylaldehyde functional molecule hybridized natural brucite-based composite powder, and preparation method and application thereof | 江西广源化工有限责任公司 | 2024-09-03 | — | — | CN | claimed |
| EP-2080750-B1 | RADIATION-SENSITIVE COMPOSITION | MITSUBISHI GAS CHEMICAL CO (JP) | 2020-07-29 | — | — | EP | claimed |
| CN-118580205-A | Use of PSF-LncRNA interaction inhibitor in preparation of medicine for treating cancer | 山东铂源药业股份有限公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-118580016-A | Nicotinamide ribochlorate-based salicylaldehyde functional molecule hybridized natural brucite-based composite powder, and preparation method and application thereof | 江西广源化工有限责任公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-105593224-B | Novel quinazolinones as bromodomain inhibitors | 恒元生物医药科技(苏州)有限公司 | 2021-05-25 | — | — | CN | disclosed |
| CN-108008600-B | Radiation-sensitive composition | 三菱瓦斯化学株式会社 | 2021-02-09 | — | — | CN | disclosed |
| EP-2080750-B1 | RADIATION-SENSITIVE COMPOSITION | MITSUBISHI GAS CHEMICAL CO (JP) | 2020-07-29 | — | — | EP | disclosed |
| EP-3027604-B1 | NOVEL QUINAZOLINONES AS BROMODOMAIN INHIBITORS | ZENITH EPIGENETICS LTD (CA) | 2019-02-20 | — | — | EP | disclosed |
| US-10000488-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2018-06-19 | — | — | US | disclosed |
| US-20180092924-A1 | NOVEL QUINAZOLINONES AS BROMODOMAIN INHIBITORS | RVX THERAPEUTICS INC. (CA) | 2018-04-05 | — | — | US | disclosed |
| US-9897913-B2 | Radiation-sensitive composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2018-02-20 | — | — | US | disclosed |
| EP-0420808-B1 | Pyran-containing phthalides | CIBA GEIGY AG (CH) | 1995-03-01 | — | — | EP | disclosed |
| CN-1072677-A | Aromatic amidine derivative and salt thereof | DAIICHI SEIYAKU CO (JP) | 1993-06-02 | — | — | CN | disclosed |
| US-5210232-A | Pyran-containing phthalides | CIBA-GEIGY CORPORATION (US) | 1993-05-11 | — | — | US | disclosed |
| EP-0540051-A1 | Aromatic amidine derivatives and salts thereof | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1993-05-05 | — | — | EP | disclosed |
| US-5097044-A | PYRAN-CONTAINING PHTHALIDES | CIBA-GEIGY CORPORATION (US) | 1992-03-17 | — | — | US | disclosed |
| EP-0437185-A2 | Pyrroline-resp. indoline containing phthalides | CIBA-GEIGY AG (CH) | 1991-07-17 | — | — | EP | disclosed |
| EP-0420808-A2 | Pyran-containing phthalides | CIBA-GEIGY AG (CH) | 1991-04-03 | — | — | EP | disclosed |
| US-4018891-A | INHIBITORS OF ANTIGEN-ANTIBODY REACTIONS | RICHARDSON-MERRELL INC. (US) | 1977-04-19 | — | — | US | disclosed |
| US-3960892-A | ANTIGEN-ANTIBODY REACTION INHIBITION | RICHARDSON-MERRELL INC. (US) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180092924-A1 | NOVEL QUINAZOLINONES AS BROMODOMAIN INHIBITORS | BRD4, BRD3, BRDT | TRIM24 458/4885TYR 4338/4885TRIM33 823/4885 |
| US-10000488-B2 | Heterocyclic compound | RORC, RORB, RORA | TRIM24 1501/4885TYR 2795/4885TRIM33 2001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.